GNI Group Ltd.
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also …
Biotechnology
JP, Tokyo [HQ]
Ratios
14 Records · Starting from 2010Margins, Growth Rates In %
| Ratio | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||
| Gross Margin | 77.33 | 19.81 | 21.37 | 9.39 | 66.05 | 76.30 | 85.49 | 81.31 | 83.10 | 85.89 | 84.18 | 87.39 | 84.65 | 86.24 | |
| Profit Margin | -94.58 | -482.06 | -297.79 | -398.03 | -69.08 | -61.29 | -39.26 | -6.62 | 3.83 | 8.46 | 12.87 | 0.44 | -4.98 | 31.12 | |
| Operating Margin | -98.59 | -506.24 | -286.87 | -427.64 | -116.00 | -62.28 | -21.15 | 5.82 | 11.33 | 17.49 | 19.13 | 12.80 | 7.91 | 17.61 | |
|
EPS Growth
|
- - | -67.22 | -0.50 | -47.68 | 59.29 | -88.36 | 17.82 | 69.00 | 201.72 | 214.56 | 94.23 | -95.93 | -1,650.00 | 1,026.74 | |
| EPS JPY | -961.00 | -1,607.00 | -1,615.00 | -2,385.00 | -971.00 | -1,829.00 | -1,503.00 | -466.00 | 474.00 | 1,491.00 | 2,896.00 | 118.00 | -1,829.00 | 16,950.00 | |
| Return on Assets (ROA) | -26.83 | -27.81 | -30.71 | -15.38 | -4.85 | -9.76 | -8.82 | -1.10 | 1.11 | 3.06 | 5.42 | 0.18 | -2.56 | 12.97 | |
| Return on Equity (ROE) | -28.18 | -43.60 | -52.73 | -25.80 | -7.41 | -16.25 | -15.73 | -1.50 | 1.60 | 5.89 | 11.44 | 0.29 | -4.14 | 23.95 | |
| Return on Invested Capital (ROIC) | -29.51 | -36.67 | -36.33 | -25.68 | -11.24 | -14.01 | -8.48 | 0.24 | 2.09 | 5.38 | 11.09 | 0.41 | -7.24 | 9.24 | |
| Solvency | |||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 16.08 | 23.37 | 8.50 | 7.55 | 10.62 | 11.66 | 8.33 | 13.46 | 9.89 | 7.52 | 3.72 | 1.59 | 5.69 | |
| Debt/Equity | - - | 25.20 | 40.12 | 14.26 | 11.53 | 17.68 | 20.81 | 11.28 | 19.41 | 19.07 | 15.88 | 5.97 | 2.56 | 10.50 | |
| Debt/EBITDA | 359.68 | 145.22 | 121.14 | 415.87 | 1,149.86 | 415.56 | 1,004.38 | -1,099.62 | -340.98 | -357.08 | -381.95 | -618.62 | -486.79 | -345.61 | |
|
Debt/Capitalization
|
- - | 20.13 | 28.63 | 12.48 | 10.34 | 15.03 | 17.23 | 10.14 | 16.25 | 16.01 | 13.70 | 5.64 | 2.50 | 9.50 | |
| Long-Term Debt/Capitalization | - - | 19.93 | 22.20 | 9.92 | 8.43 | 10.90 | 13.02 | 3.93 | 11.30 | 9.76 | 2.02 | 1.47 | 0.75 | 5.59 | |
| Interest Debt per Share JPY | -0.69 | 9.35 | 12.61 | 13.50 | 15.44 | 21.21 | 23.65 | 36.06 | 63.16 | 51.65 | 42.74 | 37.81 | 29.64 | 100.52 | |
| Debt Growth | - - | - - | 45.77 | 10.10 | 26.34 | 32.88 | 0.07 | 94.83 | 76.38 | -12.60 | -14.30 | -35.52 | -52.29 | 588.45 | |
| Liquidity | |||||||||||||||
| Current Ratio | 1,670.82 | 589.43 | 360.40 | 1,223.49 | 1,461.21 | 650.93 | 483.05 | 440.51 | 489.25 | 318.43 | 197.24 | 715.13 | 489.43 | 396.56 | |
| Quick Ratio | 1,596.50 | 554.40 | 332.23 | 1,183.81 | 1,400.74 | 622.56 | 448.87 | 397.63 | 449.68 | 293.34 | 183.08 | 660.76 | 441.10 | 366.66 | |
| Cash Ratio | 1,208.34 | 513.68 | 314.91 | 1,123.47 | 1,358.40 | 489.96 | 340.84 | 281.91 | 315.07 | 238.62 | 156.32 | 564.34 | 315.38 | 277.57 | |
| Operating Cash Flow Ratio | -200 | -100 | -100 | -200 | -100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | |||||||||||||||
| Inventory Turnover | 181.25 | 136.08 | 173.17 | 135.92 | 73.13 | 137.63 | 72.78 | 77.62 | 138.69 | 130.23 | 165.37 | 115.75 | 157.93 | 153.58 | |
| Receivables Turnover | 206.49 | 222.41 | 439.68 | 343.49 | 550.19 | 1,575.62 | 484.45 | 359.37 | 611.44 | 626.36 | 714.08 | 673.19 | 557.86 | 654.61 | |
| Payables Turnover | 274.79 | 94.86 | 290.79 | 442.05 | 282.39 | 222.46 | 113.60 | 348.36 | 389.59 | 386.63 | 375.10 | 431.24 | 281.63 | 173.36 | |
|
Asset Turnover
|
28.37 | 5.77 | 10.31 | 3.86 | 7.02 | 15.92 | 22.46 | 16.68 | 28.96 | 36.13 | 42.09 | 41.89 | 51.37 | 41.69 | |
| Fixed Turnover | 646.12 | 56.04 | 77.30 | 74.45 | 84.09 | 136.76 | 211.91 | 181.30 | 244.11 | 266.54 | 309.60 | 333.12 | 370.11 | 429.70 | |
| Coverage | |||||||||||||||
| Interest Coverage | 1,462.26 | -26,463.72 | -4,883.94 | -8,268.20 | -4,993.43 | -1,429.82 | -215.32 | 449.61 | 251.72 | 903.80 | 1,704.20 | 250.80 | 158.40 | 366.24 | |
| Asset Coverage | - - | 400 | 300 | 900 | 1,100 | 800 | 700 | 1,000 | 600 | 800 | 900 | 2,300 | 5,100 | 1,400 | |
| Cash Flow Coverage (CFGR) | - - | -65.15 | -95.88 | -164.07 | -111.10 | -56.35 | -76.43 | -23.84 | 26.16 | 38.68 | 78.85 | 49.03 | 73.20 | 184.53 | |
| EBITDA Coverage | 800 | -21,000 | -3,900 | -7,700 | -3,500 | -1,200 | -100 | 700 | 300 | 1,000 | 2,000 | 300 | 200 | 400 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | 800 | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | |||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | 0.24 | - - | 0.65 | - - | - - | 0.22 | - - | - - | |
| Earnings Yield | -9.95 | -5.42 | -3.97 | -1.53 | -0.91 | -2.87 | -2.07 | -0.24 | 0.46 | 0.57 | 1.60 | 0.08 | -1.31 | 5.99 | |
|
Price/Earnings (P/E)
|
-10.0549 | -18.4576 | -25.1799 | -65.2665 | -110.1707 | -34.8013 | -48.3367 | -424.4970 | 215.3284 | 176.0411 | 62.4219 | 1,257.9779 | -76.1659 | 16.6957 | |
| Price/Earnings Growth (PEG) | - - | -27.46 | -5,058.02 | -136.89 | 185.83 | -39.38 | 271.19 | 615.25 | -106.75 | 82.05 | 66.24 | -1,311.41 | 4.62 | -1.63 | |
|
Price/Book (P/B)
|
283.33 | 804.77 | 1,327.75 | 1,683.70 | 816.27 | 565.43 | 760.54 | 634.66 | 344.37 | 1,037.13 | 713.95 | 368.47 | 315.37 | 399.88 | |
| Price/Tangible Book (P/TB) | 283.33 | 804.77 | 1,327.75 | 1,683.70 | 816.27 | 565.43 | 760.54 | 634.66 | 344.37 | 1,037.13 | 713.95 | 368.47 | 315.37 | 399.88 | |
| Price/Sales (P/S) | 951.00 | 8,897.56 | 7,498.40 | 25,977.79 | 7,611.02 | 2,133.09 | 1,897.70 | 2,808.22 | 824.48 | 1,489.26 | 803.52 | 547.62 | 379.65 | 519.55 | |
|
Price/Cash Flow (P/CF)
|
-1,987.89 | -4,901.15 | -3,451.53 | -7,195.79 | -6,371.43 | -5,674.07 | -4,781.37 | -23,594.00 | 6,781.10 | 14,062.07 | 5,701.17 | 12,583.47 | 16,813.59 | 2,063.39 | |
| Price/Free CF (P/FCF) | -1,965.34 | -3,630.89 | -3,041.84 | -5,495.13 | -4,260.03 | -3,277.08 | -4,703.12 | -11,687.82 | -17,611.72 | 63,064.29 | 7,696.47 | -48,893.98 | -4,275.76 | 3,020.96 | |
| Price/Operating CF (P/OCF) | -1,987.89 | -4,901.15 | -3,451.53 | -7,195.79 | -6,371.43 | -5,674.07 | -4,781.37 | -23,594.00 | 6,781.10 | 14,062.07 | 5,701.17 | 12,583.47 | 16,813.59 | 2,063.39 |